- Article
- Source: Campus Sanofi
T1DM - Meta-Analysis
T1-Meta Analysis
Download this clinical summary to read about the benefits of Toujeo® Insulin Glargine 300U/ml in this post-hoc meta-analysis of three Edition 6 month, phase III, randomised trials. The study aimed to explore the risk of hypoglycaemia with Toujeo® vs insulin glargine 100U/mL in a broad pool of people with T1DM including children over the age of 6.
Our Products
.jpg/jcr:content.jpg){kind=logo}
entry-site-modal-text
Welcome to Sanofi Campus Ireland
This site is intended for Healthcare Professionals in the Republic of Ireland and contains information on Sanofi Ireland medicine, educational resources and more. Please click the appropriate button below. By entering this site, you are confirming that you are a Healthcare Professional in the Republic of Ireland. This site contains promotional information.
MAT-IE-2300185 (v4.0)
Date of Preparation: June 2024